Association of neutrophil-to-lymphocyte ratio (NLR) with the infarct size in acute myocardial infarction (AMI), through peak creatine kinase (CK) and peak creatine kinase-myocardial band (CK-MB): A retrospective observational study

中性粒细胞与淋巴细胞比值(NLR)与急性心肌梗死(AMI)梗死面积的相关性,通过肌酸激酶(CK)峰值和肌酸激酶-MB峰值(CK-MB)进行评估:一项回顾性观察研究

阅读:1

Abstract

The neutrophil-to-lymphocyte ratio (NLR) has emerged as a marker of systemic inflammation and a prognostic indicator in acute myocardial infarction (AMI). Simultaneously, infarct size (reflected by peak serum levels of creatine kinase (CK) and creatine kinase-myocardial band [CK-MB]) correlates with clinical outcomes in AMI. Given the inflammatory nature of infarction, elevated NLR at admission may contribute to larger infarct size and higher CK and CK-MB levels; however, this association has not been clearly established. We retrospectively analyzed data from 170 patients hospitalized for AMI. Univariate and multivariate linear regression analyses were conducted to examine associations between peak creatine kinase (peak CK) and CK-MB levels and clinical variables, including age, sex, body mass index, hemoglobin, creatinine, uric acid, B-type natriuretic peptide, albumin, C-reactive protein, mean blood pressure, NLR, and platelet-to-lymphocyte ratio at admission. Structural equation modeling was also employed to explore the relationship between NLR and infarct size. Multivariate analysis revealed a significant positive association between NLR at admission and both peak CK (β = 0.342, P = .002) and peak creatine kinase-myocardial band (β = 0.352, P = .001). Structural equation modeling confirmed these findings, showing significant correlations between NLR and peak CK (β = 0.342, P = .001) and CK-MB (β = 0.352, P < .001). Elevated NLR at admission is significantly associated with increased peak CK and CK-MB levels in patients with AMI, suggesting a potential link between systemic inflammation and infarct size. NLR may serve as an early, accessible predictor of infarct magnitude following AMI.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。